Your browser doesn't support javascript.
loading
F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial.
Beck, M; Hartwich, J; Eckstein, M; Schmidt, D; Gostian, A O; Müller, S; Rutzner, S; Gaipl, U S; von der Grün, J; Illmer, T; Hautmann, M G; Klautke, G; Döscher, J; Brunner, T; Tamaskovics, B; Hartmann, A; Iro, H; Kuwert, T; Fietkau, R; Hecht, M; Semrau, S.
Affiliation
  • Beck M; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Bayern, Germany. michael.beck@uk-erlangen.de.
  • Hartwich J; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Bayern, Germany.
  • Eckstein M; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Schmidt D; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Bayern, Germany.
  • Gostian AO; Department of Otolaryngology-Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Müller S; Department of Otolaryngology-Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Rutzner S; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Gaipl US; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • von der Grün J; Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
  • Illmer T; Medical Oncology Clinic Dresden Freiberg, Dresden, Saxony, Germany.
  • Hautmann MG; Department of Radiotherapy, Universität Regensburg, Regensburg, Bayern, Germany.
  • Klautke G; Department of Radiation Oncology, Chemnitz Hospital, Chemnitz, Sachsen, Germany.
  • Döscher J; Department of Otolaryngology-Head and Neck Surgery, Universität Ulm, Ulm, Baden-Württemberg, Germany.
  • Brunner T; Department of Radiation Oncology, Otto Von Guericke Universität Magdeburg, Magdeburg, Sachsen-Anhalt, Germany.
  • Tamaskovics B; Department of Radiation Oncology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Nordrhein-Westfalen, Germany.
  • Hartmann A; Institute of Pathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Iro H; Department of Otolaryngology-Head and Neck Surgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Kuwert T; Clinic of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg, University Hospital Erlangen, Ulmenweg 18, 91054, Erlangen, Bayern, Germany.
  • Fietkau R; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Hecht M; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
  • Semrau S; Department of Radiation Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Bayern, Germany.
Ann Nucl Med ; 36(7): 623-633, 2022 Jul.
Article in En | MEDLINE | ID: mdl-35534690

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / Head and Neck Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Nucl Med Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fluorodeoxyglucose F18 / Head and Neck Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Ann Nucl Med Journal subject: MEDICINA NUCLEAR Year: 2022 Type: Article Affiliation country: Germany